SCHEMBL4606197

SCHEMBL4606197

CC(C)(C)C(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.50
TSHR P16473 4/20 0.41
NPC1 O15118 2/20 0.41
GAA P10253 2/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PKM P14618 1/20 0.39
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37
MAPK1 P28482 1/20 0.37
ALOX15 P16050 1/20 0.35
USP2 O75604 1/20 0.35
ESR1 P03372 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027536 0.80 HSP90AA1 (0.50) HSP90AA1TSHRNPC1GAAKMT2A
SCHEMBL1508 0.77 HSP90AA1 (0.55) HSP90AA1TSHRNPC1GAAKMT2A
SCHEMBL11093964 0.77 TSHR (0.43) HSP90AA1TSHRGAAKMT2AMEN1
SCHEMBL814 0.76 HSP90AA1 (0.59) HSP90AA1TSHRGAAKMT2AMEN1
SCHEMBL7522374 0.76 HSP90AA1 (0.59) HSP90AA1TSHRGAAKMT2AMEN1
SCHEMBL360684 0.76 HSP90AA1 (0.46) HSP90AA1TSHRNPC1GAAKMT2A
Acetic Acid SCHEMBL30721072 0.75 HSP90AA1 (0.53) HSP90AA1TSHRNPC1HTTKMT2A
Bromide SCHEMBL8168614 0.74 HSP90AA1 (0.45) HSP90AA1TSHRNPC1GAAKMT2A
SCHEMBL15831129 0.74 HSP90AA1 (0.45) HSP90AA1TSHRGAAKMT2AMEN1
Acetaldehyde SCHEMBL31570102 0.73 HSP90AA1 (0.52) HSP90AA1TSHRNPC1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351686-B2 Curable resin composition, dry film and cured product of same, and electronic component containing said cured product TAIYO HOLDINGS CO., LTD. (JP) 2025-07-08 US disclosed
CN-114269857-B Curable resin composition, dry film and cured product thereof, and electronic component comprising the cured product 太阳控股株式会社 2025-02-25 CN disclosed
US-20220325047-A1 CURABLE RESIN COMPOSITION, DRY FILM AND CURED PRODUCT OF SAME, AND ELECTRONIC COMPONENT CONTAINING SAID CURED PRODUCT TAIYO INK MFG. CO., LTD. (JP) 2022-10-13 US disclosed
CN-114269857-A Curable resin composition, dry film and cured product thereof, and electronic component comprising cured product 太阳油墨制造株式会社 2022-04-01 CN disclosed
WO-2021045085-A1 CURABLE RESIN COMPOSITION, DRY FILM AND CURED PRODUCT OF SAME, AND ELECTRONIC COMPONENT CONTAINING SAID CURED PRODUCT 太陽インキ製造株式会社 2021-03-11 WO disclosed
EP-1341039-B1 PHOTOCURABLE AND THERMOSETTING RESIN COMPOSITION UNIV KANAGAWA (JP) 2008-07-09 EP disclosed
US-7238763-B2 Unsaturated monocarboxylic ester compounds KANAGAWA UNIVERSITY AND TAIYO INK MANUFACTURING CO., LTD. (JP) 2007-07-03 US disclosed
US-7226710-B2 Photocurable/therosetting resin composition, photosensitive dry film formed therefrom and method of forming pattern with the same KANAGAWA UNIVERSITY (JP) 2007-06-05 US disclosed
US-7208568-B2 Resin curable with actinic radiation, process for the production thereof, and photocurable and thermosetting resin composition KANAGAWA UNIVERSITY (JP) 2007-04-24 US disclosed
EP-1251118-B1 UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY UNIV KANAGAWA (JP) 2006-12-20 EP disclosed
EP-1251118-A1 UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY Kanagawa University (JP) 2002-10-23 EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 US disclosed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 WO disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP disclosed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO disclosed
EP-0227826-B1 NOVEL VITAMIN D ANALOGUES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1989-10-25 EP disclosed
US-4866048-A TREATMENT OF ABNORMAL CALL POLIIFERATION OR DIFFERENTIATION LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1989-09-12 US disclosed